Here's what we've learned through our observations and feedback from the broader research community: Gastrointestinal Sensitivity Tirzepatide is known to affect gastrointestinal motility, often leading to side effects like nausea, vomiting, diarrhea, or constipation, especially during initial titration or with higher doses
AMPLITUDE-O: Efpeglenatide reduces CV events, CKD progression in high-risk type 2 diabetes A novel GLP-1 receptor agonist reduced cardiovascular event risk by 27% and kidney disease progression by 32% compared with placebo for high-risk adults with type 2 diabetes, with or without background SGLT2 inhibitor therapy, data show
NNMT is expressed most highly in human liver (RPKM 188.3), followed by the appendix (RPKM 69.3) and approximately ten other tissues, with a biased expression pattern
That produces 6.67 mg/mL, where a 500 mcg dose is 7.5 units and 1,000 mcg is 15 units